NASDAQ:AARD | News | Aardvark Therapeutics, Inc.

AARD News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-17Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 5.07.
2026-08-11Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-06-12Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01.
2026-05-14Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2026-05-07Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-03-24Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01.
2026-03-23Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-02-27Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2026-02-12Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 5.02,8.01,9.01.
2026-02-10Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2026-01-12Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2025-12-10Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2025-11-13Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-11-06Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2025-11-04Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01.
2025-10-09Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2025-09-03Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2025-08-13Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-08-12Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2025-05-14Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-03-31Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-02-14Current reportSEC filingAardvark Therapeutics, Inc. filed Form 8-KAardvark Therapeutics, Inc. filed Form 8-K covering items 5.03,8.01,9.01.